Picture of Hugel logo

145020 — Hugel News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Hugel Receives US FDA Approval For Its Neurotoxin Letybo

March 4 (Reuters) - Hugel Inc  145020.KQ :
    * HUGEL RECEIVES FDA APPROVAL IN THE UNITED STATES OF LETYBO
(LETIBOTULINUMTOXINA-WLBG) FOR INJECTION FOR THE TREATMENT OF
GLABELLAR LINES
    * HUGEL INC: PLANS TO ACCELERATE TRANSITION FOR APPROVED
MEDICAL
USE WITH GOAL OF LAUNCHING TO AESTHETIC CLINICIANS IN BACK HALF
2024

Source text for Eikon:  ID:nPn1B48Yga 
Further company coverage:  145020.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Hugel

See all news